| Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus G Mushtaq, N H Greig, J A Khan, M A Kamal CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 340 | 2014 |
| Inflammatory process in Alzheimer’s and Parkinson's diseases: central role of cytokines Q Alam, M Zubair Alam, G Mushtaq, G A Damanhouri, M Rasool, ... Current pharmaceutical design 22 (5), 541-548, 2016 | 239 | 2016 |
| The diabetic brain and cognition P Riederer, AD Korczyn, SS Ali, O Bajenaru, MS Choi, M Chopp, ... Journal of neural transmission 124, 1431-1454, 2017 | 124 | 2017 |
| Clinical biomarkers in sickle cell disease GA Damanhouri, J Jarullah, S Marouf, SI Hindawi, G Mushtaq, MA Kamal Saudi journal of biological sciences 22 (1), 24-31, 2015 | 92 | 2015 |
| Alzheimer’s disease and type 2 diabetes via chronic inflammatory mechanisms G Mushtaq, JA Khan, TA Kumosani, MA Kamal Saudi journal of biological sciences 22 (1), 4-13, 2015 | 87 | 2015 |
| miRNAs as circulating biomarkers for Alzheimer’s disease and Parkinson’s disease G Mushtaq, N H. Greig, F Anwar, M A. Zamzami, H Choudhry, M M. Shaik, ... Medicinal chemistry 12 (3), 217-225, 2016 | 83 | 2016 |
| Solid matrix based lipidic nanoparticles in oral cancer chemotherapy: applications and pharmacokinetics J Ahmad, S Amin, M Rahman, R Abdur Rub, M Singhal, M Zaki Ahmad, ... Current drug metabolism 16 (8), 633-644, 2015 | 75 | 2015 |
| Psychopharmacology of attention-deficit hyperactivity disorder: effects and side effects J Golmirzaei, H Mahboobi, M Yazdanparast, G Mushtaq, M A Kamal, ... Current pharmaceutical design 22 (5), 590-594, 2016 | 67 | 2016 |
| Neuroprotective mechanisms mediated by CDK5 inhibition G Mushtaq, N H Greig, F Anwar, F A Al-Abbasi, M A Zamzami, ... Current pharmaceutical design 22 (5), 527-534, 2016 | 67 | 2016 |
| In silico analysis of green tea polyphenols as inhibitors of AChE and BChE enzymes in Alzheimer’s disease treatment B Ali, Q MS Jamal, S Shams, N A Al-Wabel, M U Siddiqui, M A Alzohairy, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016 | 64 | 2016 |
| Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer disease and other neurodegenerative diseases: an in silico-updated overview K Ahmad, M Hassan Baig, G Mushtaq, M Amjad Kamal, N H. Greig, I Choi Current Alzheimer Research 14 (11), 1190-1197, 2017 | 62 | 2017 |
| Inhibition on the growth of human MDA-MB-231 breast cancer cells in vitro and tumor growth in a mouse xenograft model by Se-containing polysaccharides from Pyracantha fortuneana C Yuan, C Wang, J Wang, V Kumar, F Anwar, F Xiao, G Mushtaq, Y Liu, ... Nutrition Research 36 (11), 1243-1254, 2016 | 60 | 2016 |
| Role of graphene nano-composites in cancer therapy: theranostic applications, metabolic fate and toxicity issues M Rahman, M Zaki Ahmad, J Ahmad, J Firdous, F Jalees Ahmad, ... Current drug metabolism 16 (5), 397-409, 2015 | 60 | 2015 |
| Recent updates on the association between Alzheimer’s disease and vascular dementia G M Ashraf, S Chibber, S K Zaidi, S Tabrez, A Ahmad, S Shakil, ... Medicinal Chemistry 12 (3), 226-237, 2016 | 56 | 2016 |
| Current update on synopsis of miRNA dysregulation in neurological disorders M A Kamal, G Mushtaq, N H Greig CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015 | 52 | 2015 |
| Nanoparticles, neurotoxicity and neurodegenerative diseases G Mushtaq, J A Khan, E Joseph, M A Kamal Current drug metabolism 16 (8), 676-684, 2015 | 51 | 2015 |
| Current understanding of HSP90 as a novel therapeutic target: an emerging approach for the treatment of cancer A Haque, Q Alam, M Zubair Alam, E I. Azhar, K Hussain Wali Sait, ... Current pharmaceutical design 22 (20), 2947-2959, 2016 | 46 | 2016 |
| Combination of selenium‐enriched green tea polysaccharides and Huo‐ji polysaccharides synergistically enhances antioxidant and immune activity in mice C Yuan, Z Li, F Peng, F Xiao, D Ren, H Xue, T Chen, G Mushtaq, ... Journal of the Science of Food and Agriculture 95 (15), 3211-3217, 2015 | 43 | 2015 |
| Biological mechanisms linking Alzheimer’s disease and type-2 diabetes mellitus G Mushtaq, J A Khan, M A Kamal CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 42 | 2014 |
| Applications of nanotechnology in diagnostics and therapeutics of Alzheimer’s and Parkinson’s disease G Soursou, A Alexiou, G Md Ashraf, A Ali Siyal, G Mushtaq, M A Kamal Current Drug Metabolism 16 (8), 705-712, 2015 | 34 | 2015 |
